Form 8-K - Current report:
SEC Accession No. 0000950170-23-007252
Filing Date
2023-03-10
Accepted
2023-03-10 15:46:00
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K acet-20230310.htm   iXBRL 8-K 54061
  Complete submission text file 0000950170-23-007252.txt   175528

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20230310_pre.xml EX-101.PRE 10289
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20230310.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20230310_lab.xml EX-101.LAB 14018
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20230310_htm.xml XML 4933
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 23723430
SIC: 2834 Pharmaceutical Preparations